Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04608-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Biswajit Kumar Utpal und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, 1207, Bangladesh. Hauptthemen laut MEDLINE: Resveratrol, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 165 Literaturangaben.
Abstract (Originalsprache)
Neurological diseases (NDs), including neurodegenerative disorders and acute injuries, are a significant global health concern. The PI3K/Akt/mTOR pathway, a crucial signaling cascade, is responsible for the survival of cells, proliferation, and metabolism. Dysregulation of this pathway has been linked to neurological conditions, indicating its potential as a vital target for therapeutic approaches. Resveratrol (RSV), a natural compound found in berries, peanuts, and red grapes, has antioxidant, anti-cancer, and anti-inflammatory effects. Its ability to modulate the PI3K/Akt/mTOR pathway has been interesting in NDs. Studies have shown that RSV can activate the PI3K/Akt pathway, promoting cell survival and inhibiting apoptosis of neuronal cells. Its impact on mTOR, a downstream effector of Akt, further contributes to its neuroprotective effects. RSV's ability to restore autophagic flux presents a promising avenue for therapeutic intervention. Its anti-inflammatory properties suppress inflammatory responses by inhibiting key signaling molecules within the pathway. Additionally, RSV's role in enhancing mitochondrial function contributes to its neuroprotective profile. This study highlights RSV's potential as a multifaceted therapeutic agent in NDs, specifically by PI3K/Akt/mTOR pathway modulation. Additional investigation is required to optimize its therapeutic capacity in diverse neurological conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, 1207, Bangladesh.
- Laboratory of AgroBiotechnology and Nutrition in Semi Arid Zones, Faculty of Nature and Life Sciences, University of Ibn Khaldoun, Tiaret, Algeria.
- Department of Clinical Pharmacy, College of Dentistry & Pharmacy, Buraydah Private Colleges, Buraydah, 51418, Saudi Arabia. mahrukh.zehravi@hotmail.com.
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.
- Department of Pharmacognosy, Faculty of Pharmacy, Egyptian Russian University, Cairo-Suez Road, Badr City, Cairo, 11829, Egypt.
- Department of Pharmacology, Institute of Pharmaceutical Research, GLA University Mathura, Chaumuha, Mathura, Uttar Pradesh, 281406, India.
Zitieren
APA
Utpal, B. K., Mokhfi, F. Z., Zehravi, M., Sweilam, S. H., Gupta, J. K., Kareemulla, S., C, R. D., Rao, A. A., Kumar, V. V., Krosuri, P., Prasad, D., Khan, S. L., Roy, S. C., Rab, S. O., Alshehri, M. A., & Emran, T. B. (2025). Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04608-4
Vancouver
Utpal BK, Mokhfi FZ, Zehravi M, Sweilam SH, Gupta JK, Kareemulla S, et al. Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04608-4
BibTeX
@article{Utpal2025,
author = {Utpal, Biswajit Kumar and Mokhfi, Fatima Zohra and Zehravi, Mehrukh and Sweilam, Sherouk Hussein and Gupta, Jeetendra Kumar and Kareemulla, Shaik and C, Ronald Darwin and Rao, A Anka and Kumar, Voleti Vijaya and Krosuri, Pavankumar and Prasad, Dharani and Khan, Sharukh L and Roy, Sajib Chandra and Rab, Safia Obaidur and Alshehri, Mohammed Ali and Emran, Talha Bin},
title = {Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04608-4}
}
EUVIMED